Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Electrocardiographic changes during initiation of lithium augmentation of antidepressant pharmacotherapy

Title: Electrocardiographic changes during initiation of lithium augmentation of antidepressant pharmacotherapy
Authors: Berger, M.; Kermer, J.; Behr, J.; Schulz-Menger, J.; Bilal, S.; Osterland, S.L.; O'Malley, G.; Bschor, T.; Schlattmann, P.; Stamm, T.; Steinacher, B.; de Millas, W.; Richter, C.; Heinz, A.; Adli, M.; Buspavanich, P.; Ricken, R.
Publisher Information: Lippincott Williams & Wilkins
Publication Year: 2022
Collection: Max-Delbrueck-Center for Molecular Medicine, Berlin: MDC Repository
Subject Terms: Cardiovascular and Metabolic Diseases; Topic 3: Integrative Biomedicine
Description: PURPOSE/BACKGROUND: Lithium augmentation of antidepressants represents a common strategy to overcome treatment resistance in patients with major depressive disorder. The use of lithium has been associated with cardiovascular adverse effects such as QTc prolongation and tachyarrhythmia. Although the previous studies investigated monotherapy with lithium, the aim of this study was to investigate electrocardiographic changes in LA. METHODS/PROCEDURES: A 12-lead surface electrocardiogram (ECG) was obtained from 38 patients with major depressive disorder before and during LA. Changes in heart rate, PQ, QRS and QTc interval, QT dispersion, ST segment, and T- and U-wave alterations were analyzed using a linear mixed model. FINDINGS/RESULTS: The ECG readings of 33 patients were evaluated. Lithium augmentation was not significantly associated with changes in heart rate, QTc, PQ, or QRS interval. We found a significant decrease in QT dispersion. These results were independent of sex, age, stable comedication, and comorbidities. During LA, we observed 9 cases of T-wave alterations and 2 cases of new U waves. CONCLUSIONS: Our data provide no evidence for serious ECG abnormalities at therapeutic serum lithium levels in patients treated with LA. In particular, we did not find evidence for QTc time lengthening or tachyarrhythmia, such as torsades des pointes. The recommended intervals for ECG checks should be considered to detect long-term effects of LA.
Document Type: article in journal/newspaper
Language: unknown
Relation: Electrocardiographic changes during initiation of lithium augmentation of antidepressant pharmacotherapy. Berger, M., Kermer, J., Behr, J., Schulz-Menger, J., Bilal, S., Osterland, S.L., O'Malley, G., Bschor, T., Schlattmann, P., Stamm, T., Steinacher, B., de Millas, W., Richter, C., Heinz, A., Adli, M., Buspavanich, P. and Ricken, R. Journal of Clinical Psychopharmacology 42 (1): 87-91. January 2022; PMID:34854829; https://doi.org/10.1097/JCP.0000000000001496
DOI: 10.1097/JCP.0000000000001496
Availability: https://edoc.mdc-berlin.de/id/eprint/21142/; https://edoc.mdc-berlin.de/21142/; https://doi.org/10.1097/JCP.0000000000001496
Accession Number: edsbas.2DFD4A7C
Database: BASE